EE+ POEM Archive
Sarilumab increases remission, decreases steroid dose in polymyalgia rheumatica taper, but at a high cost (SAPHYR)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Sarilumab Increases Remission, Decreases Steroid Dose in Polymyalgia Rheumatica Taper, but at a High Cost (SAPHYR)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377013/all/Sarilumab_increases_remission__decreases_steroid_dose_in_polymyalgia_rheumatica_taper__but_at_a_high_cost__SAPHYR_.
Sarilumab increases remission, decreases steroid dose in polymyalgia rheumatica taper, but at a high cost (SAPHYR). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377013/all/Sarilumab_increases_remission__decreases_steroid_dose_in_polymyalgia_rheumatica_taper__but_at_a_high_cost__SAPHYR_. Accessed September 7, 2024.
Sarilumab increases remission, decreases steroid dose in polymyalgia rheumatica taper, but at a high cost (SAPHYR). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377013/all/Sarilumab_increases_remission__decreases_steroid_dose_in_polymyalgia_rheumatica_taper__but_at_a_high_cost__SAPHYR_
Sarilumab Increases Remission, Decreases Steroid Dose in Polymyalgia Rheumatica Taper, but at a High Cost (SAPHYR) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 September 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377013/all/Sarilumab_increases_remission__decreases_steroid_dose_in_polymyalgia_rheumatica_taper__but_at_a_high_cost__SAPHYR_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sarilumab increases remission, decreases steroid dose in polymyalgia rheumatica taper, but at a high cost (SAPHYR)
ID - 3377013
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377013/all/Sarilumab_increases_remission__decreases_steroid_dose_in_polymyalgia_rheumatica_taper__but_at_a_high_cost__SAPHYR_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
